Malta vs Switzerland: Share of E. coli infections resistant to cephalosporins
Malta
13.3%
in 2022
Switzerland
9.8%
in 2022
Malta rank
36th
Switzerland rank
39th
Share of E. coli infections resistant to cephalosporins over time
- Malta
- Switzerland
How they compare
Malta currently reports 13.3% against 9.8% in Switzerland, a difference of 3.5%.
That makes Malta's figure about 1.4 times Switzerland's.
Across all 6 years both countries report, Malta has been ahead every year.
Malta ranks 36th and Switzerland ranks 39th of 46 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 16.8% | 10.0% | 6.8% | Malta |
| 2020s | 12.8% | 10.1% | 2.6% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Malta or Switzerland?
- Malta, at 13.3% against 9.8% in Switzerland as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Malta and Switzerland?
- 3.5%, with Malta ahead.
- How many years of comparable data are there for Malta and Switzerland?
- 6 years are reported by both, from 2017 to 2022.
- How do Malta and Switzerland rank globally for share of e. coli infections resistant to cephalosporins?
- Malta ranks 36th and Switzerland ranks 39th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).